{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T04:48:30Z","timestamp":1782103710451,"version":"3.54.5"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Science and Technology Bureau of Yancheng City in 2022","award":["YCBE202213"],"award-info":[{"award-number":["YCBE202213"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s00210-025-04893-3","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T04:22:17Z","timestamp":1768969337000},"page":"9551-9563","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting STAT3 by SH-4\u201354 suppresses the occurrence and inactivates oxidative phosphorylation in small-cell lung cancer via the SRC signaling"],"prefix":"10.1007","volume":"399","author":[{"given":"Chen","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongxiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongqian","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minhua","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,21]]},"reference":[{"issue":"2","key":"4893_CR1","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/cr.2008.18","volume":"18","author":"K Al Zaid Siddiquee","year":"2008","unstructured":"Al Zaid Siddiquee K, Turkson J (2008) STAT3 as a target for inducing apoptosis in solid and hematological tumors. Cell Res 18(2):254\u2013267","journal-title":"Cell Res"},{"issue":"3","key":"4893_CR2","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/sj.bjc.6600080","volume":"86","author":"V Boudny","year":"2002","unstructured":"Boudny V, Nakano S (2002) Src tyrosine kinase augments taxotere-induced apoptosis through enhanced expression and phosphorylation of Bcl-2. Br J Cancer 86(3):463\u2013469","journal-title":"Br J Cancer"},{"issue":"4","key":"4893_CR3","doi-asserted-by":"publisher","DOI":"10.4161\/jkst.25764","volume":"2","author":"J Bourgeais","year":"2013","unstructured":"Bourgeais J, Gouilleux-Gruart V, Gouilleux F (2013) Oxidative metabolism in cancer: a STAT affair? JAK-STAT 2(4):e25764","journal-title":"JAK-STAT"},{"issue":"21","key":"4893_CR4","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1038\/sj.onc.1203527","volume":"19","author":"T Bowman","year":"2000","unstructured":"Bowman T, Garcia R, Turkson J, Jove R (2000) STATs in oncogenesis. Oncogene 19(21):2474\u20132488","journal-title":"Oncogene"},{"issue":"22","key":"4893_CR5","doi-asserted-by":"publisher","first-page":"3863","DOI":"10.1007\/s00018-012-1055-9","volume":"69","author":"NP Bretz","year":"2012","unstructured":"Bretz NP, Salnikov AV, Perne C et al (2012) CD24 controls Src\/STAT3 activity in human tumors. Cell Mol Life Sci 69(22):3863\u20133879","journal-title":"Cell Mol Life Sci"},{"issue":"3","key":"4893_CR6","doi-asserted-by":"publisher","first-page":"768","DOI":"10.21037\/tlcr-19-547","volume":"9","author":"P Chen","year":"2020","unstructured":"Chen P, Kuang P, Wang L et al (2020) Mechanisms of drugs-resistance in small cell lung cancer: DNA-related, RNA-related, apoptosis-related, drug accumulation and metabolism procedure. Transl Lung Cancer Res 9(3):768\u2013786","journal-title":"Transl Lung Cancer Res"},{"issue":"1","key":"4893_CR7","first-page":"455","volume":"41","author":"Y Cheng","year":"2018","unstructured":"Cheng Y, Hao Y, Zhang A et al (2018) Persistent STAT5-mediated ROS production and involvement of aberrant p53 apoptotic signaling in the resistance of chronic myeloid leukemia to imatinib. Int J Mol Med 41(1):455\u2013463","journal-title":"Int J Mol Med"},{"issue":"5","key":"4893_CR8","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1089\/ars.2019.7898","volume":"32","author":"HY Chiu","year":"2020","unstructured":"Chiu HY, Tay EXY, Ong DST, Taneja R (2020) Mitochondrial dysfunction at the center of cancer therapy. Antioxid Redox Signal 32(5):309\u2013330","journal-title":"Antioxid Redox Signal"},{"issue":"7","key":"4893_CR9","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1016\/j.cellsig.2011.03.004","volume":"23","author":"FY Chueh","year":"2011","unstructured":"Chueh FY, Leong KF, Cronk RJ, Venkitachalam S, Pabich S, Yu CL (2011) Nuclear localization of pyruvate dehydrogenase complex-E2 (PDC-E2), a mitochondrial enzyme, and its role in signal transducer and activator of transcription 5 (STAT5)-dependent gene transcription. Cell Signal 23(7):1170\u20131178","journal-title":"Cell Signal"},{"issue":"6","key":"4893_CR10","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1593\/neo.04571","volume":"7","author":"FM Corvinus","year":"2005","unstructured":"Corvinus FM, Orth C, Moriggl R et al (2005) Persistent STAT3 activation in colon cancer is associated with enhanced cell proliferation and tumor growth. Neoplasia 7(6):545\u2013555","journal-title":"Neoplasia"},{"key":"4893_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2020.109598","volume":"71","author":"P Cui","year":"2020","unstructured":"Cui P, Wei F, Hou J, Su Y, Wang J, Wang S (2020) STAT3 inhibition induced temozolomide-resistant glioblastoma apoptosis via triggering mitochondrial STAT3 translocation and respiratory chain dysfunction. Cell Signal 71:109598","journal-title":"Cell Signal"},{"key":"4893_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcpo.2021.100318","volume":"31","author":"ICM Emmerick","year":"2022","unstructured":"Emmerick ICM, Uy K, Guiab K et al (2022) Impact of the National Lung Screening Trial (NLST) publication and Medicare lung cancer screening payment on lung cancer incidence rates: an interrupted time series analysis. J Cancer Policy 31:100318","journal-title":"J Cancer Policy"},{"issue":"11","key":"4893_CR13","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1021\/ml4003138","volume":"4","author":"S Haftchenary","year":"2013","unstructured":"Haftchenary S, Luchman HA, Jouk AO et al (2013) Potent targeting of the STAT3 protein in brain cancer stem cells: a promising route for treating glioblastoma. ACS Med Chem Lett 4(11):1102\u20131107","journal-title":"ACS Med Chem Lett"},{"key":"4893_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12061361","author":"PC Hsu","year":"2020","unstructured":"Hsu PC, Yang CT, Jablons DM, You L (2020) The crosstalk between Src and Hippo\/YAP signaling pathways in non-small cell lung cancer (NSCLC). Cancers. https:\/\/doi.org\/10.3390\/cancers12061361","journal-title":"Cancers"},{"key":"4893_CR15","doi-asserted-by":"publisher","first-page":"281","DOI":"10.3389\/fphar.2020.00281","volume":"11","author":"B Huang","year":"2020","unstructured":"Huang B, Liu J, Fu S et al (2020) Alpha-cyperone attenuates H(2)O(2)-induced oxidative stress and apoptosis in SH-SY5Y cells via activation of Nrf2. Front Pharmacol 11:281","journal-title":"Front Pharmacol"},{"issue":"49","key":"4893_CR16","doi-asserted-by":"publisher","first-page":"5636","DOI":"10.1038\/sj.onc.1203912","volume":"19","author":"RB Irby","year":"2000","unstructured":"Irby RB, Yeatman TJ (2000) Role of Src expression and activation in human cancer. Oncogene 19(49):5636\u20135642","journal-title":"Oncogene"},{"issue":"6","key":"4893_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.223","volume":"4","author":"KH Koo","year":"2013","unstructured":"Koo KH, Kim H, Bae YK et al (2013) Salinomycin induces cell death via inactivation of Stat3 and downregulation of Skp2. Cell Death Dis 4(6):e693","journal-title":"Cell Death Dis"},{"issue":"9","key":"4893_CR18","doi-asserted-by":"publisher","first-page":"3842","DOI":"10.1158\/0008-5472.CAN-08-2246","volume":"69","author":"S Kopetz","year":"2009","unstructured":"Kopetz S, Lesslie DP, Dallas NA et al (2009) Synergistic activity of the SRC family kinase inhibitor dasatinib and oxaliplatin in colon carcinoma cells is mediated by oxidative stress. Cancer Res 69(9):3842\u20133849","journal-title":"Cancer Res"},{"issue":"6","key":"4893_CR19","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1158\/1541-7786.MCR-09-0003","volume":"7","author":"EL Leung","year":"2009","unstructured":"Leung EL, Tam IY, Tin VP et al (2009) SRC promotes survival and invasion of lung cancers with epidermal growth factor receptor abnormalities and is a potential candidate for molecular-targeted therapy. Mol Cancer Res 7(6):923\u2013932","journal-title":"Mol Cancer Res"},{"issue":"10","key":"4893_CR20","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.2174\/1566524023666221024120825","volume":"23","author":"Z Liang","year":"2023","unstructured":"Liang Z, Chen Y, Gu R, Guo Q, Nie X (2023) Asiaticoside prevents oxidative stress and apoptosis in endothelial cells by activating ROS-dependent p53\/Bcl-2\/Caspase-3 signaling pathway. Curr Mol Med 23(10):1116\u20131129","journal-title":"Curr Mol Med"},{"key":"4893_CR21","first-page":"29","volume":"212","author":"M Lindauer","year":"2018","unstructured":"Lindauer M, Hochhaus A (2018) Dasatinib. Recent Results in Cancer Research Fortschritte der Krebsforschung Progres Dans Les Recherches Sur Le Cancer 212:29\u201368","journal-title":"Recent Results in Cancer Research Fortschritte der Krebsforschung Progres Dans Les Recherches Sur Le Cancer"},{"issue":"8","key":"4893_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0161202","volume":"11","author":"K Linher-Melville","year":"2016","unstructured":"Linher-Melville K, Nashed MG, Ungard RG et al (2016) Chronic inhibition of STAT3\/STAT5 in treatment-resistant human breast cancer cell subtypes: convergence on the ROS\/SUMO pathway and its effects on xCT expression and system xc- activity. PLoS One 11(8):e0161202","journal-title":"PLoS One"},{"issue":"1","key":"4893_CR23","doi-asserted-by":"publisher","first-page":"7980","DOI":"10.1038\/s41598-017-08792-3","volume":"7","author":"Y Liu","year":"2017","unstructured":"Liu Y, Tan S, Zhang H et al (2017) Selective effects of non-thermal atmospheric plasma on triple-negative breast normal and carcinoma cells through different cell signaling pathways. Sci Rep 7(1):7980","journal-title":"Sci Rep"},{"issue":"6","key":"4893_CR24","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/s41419-021-03844-z","volume":"12","author":"Z Liu","year":"2021","unstructured":"Liu Z, Ma L, Sun Y, Yu W, Wang X (2021) Targeting STAT3 signaling overcomes gefitinib resistance in non-small cell lung cancer. Cell Death Dis 12(6):561","journal-title":"Cell Death Dis"},{"key":"4893_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105983","volume":"175","author":"YX Liu","year":"2022","unstructured":"Liu YX, Xu BW, Niu XD et al (2022) Inhibition of Src\/STAT3 signaling-mediated angiogenesis is involved in the anti-melanoma effects of dioscin. Pharmacol Res 175:105983","journal-title":"Pharmacol Res"},{"key":"4893_CR26","doi-asserted-by":"publisher","DOI":"10.1172\/JCI177599","author":"SQ Liu","year":"2025","unstructured":"Liu SQ, Cheng XX, He S et al (2025) Super-enhancer-driven EFNA1 fuels tumor progression in cervical cancer via the FOSL2-Src\/AKT\/STAT3 axis. J Clin Invest. https:\/\/doi.org\/10.1172\/JCI177599","journal-title":"J Clin Invest"},{"key":"4893_CR27","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.cellsig.2019.05.003","volume":"61","author":"S Majumder","year":"2019","unstructured":"Majumder S, Ren L, Pushpakumar S, Sen U (2019) Hydrogen sulphide mitigates homocysteine-induced apoptosis and matrix remodelling in mesangial cells through Akt\/FOXO1 signalling cascade. Cell Signal 61:66\u201377","journal-title":"Cell Signal"},{"issue":"6141","key":"4893_CR28","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1126\/science.1233606","volume":"341","author":"D Martinez Molina","year":"2013","unstructured":"Martinez Molina D, Jafari R, Ignatushchenko M et al (2013) Monitoring drug target engagement in cells and tissues using the cellular thermal shift assay. Science 341(6141):84\u201387","journal-title":"Science"},{"issue":"14","key":"4893_CR29","doi-asserted-by":"publisher","first-page":"3526","DOI":"10.1158\/1078-0432.CCR-09-1834","volume":"16","author":"EL Mayer","year":"2010","unstructured":"Mayer EL, Krop IE (2010) Advances in targeting SRC in the treatment of breast cancer and other solid malignancies. Clin Cancer Res 16(14):3526\u20133532","journal-title":"Clin Cancer Res"},{"issue":"12","key":"4893_CR30","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1080\/15384047.2019.1647049","volume":"20","author":"K Memarzadeh","year":"2019","unstructured":"Memarzadeh K, Savage DJ, Bean AJ (2019) Low UBE4B expression increases sensitivity of chemoresistant neuroblastoma cells to EGFR and STAT5 inhibition. Cancer Biol Ther 20(12):1416\u20131429","journal-title":"Cancer Biol Ther"},{"key":"4893_CR31","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.lungcan.2022.05.003","volume":"169","author":"PJ Ngo","year":"2022","unstructured":"Ngo PJ, Wade S, Vaneckova P et al (2022) Health utilities for participants in a population-based sample who meet eligibility criteria for lung cancer screening. Lung Cancer 169:47\u201354","journal-title":"Lung Cancer"},{"issue":"3","key":"4893_CR32","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.suc.2021.12.001","volume":"102","author":"AL Oliver","year":"2022","unstructured":"Oliver AL (2022) Lung cancer: epidemiology and screening. Surg Clin North Am 102(3):335\u2013344","journal-title":"Surg Clin North Am"},{"key":"4893_CR33","doi-asserted-by":"crossref","unstructured":"Pang S, Luo Z, Dong W et al (2023) Integrin beta1\/FAK\/SRC signal pathway is involved in autism spectrum disorder in Tspan7 knockout rats. Life Sci Alliance 6(3):e202201616","DOI":"10.26508\/lsa.202201616"},{"key":"4893_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19061585","author":"CLC Poon","year":"2018","unstructured":"Poon CLC, Brumby AM, Richardson HE (2018) Src cooperates with oncogenic ras in tumourigenesis via the JNK and PI3K pathways in Drosophila epithelial tissue. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms19061585","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4893_CR35","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41572-020-00235-0","volume":"7","author":"CM Rudin","year":"2021","unstructured":"Rudin CM, Brambilla E, Faivre-Finn C, Sage J (2021) Small-cell lung cancer. Nat Rev Dis Primers 7(1):3","journal-title":"Nat Rev Dis Primers"},{"key":"4893_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15020372","author":"S Sabetta","year":"2023","unstructured":"Sabetta S, Vecchiotti D, Clementi L, Di Vito Nolfi M, Zazzeroni F, Angelucci A (2023) Comparative analysis of dasatinib effect between 2D and 3D tumor cell cultures. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics15020372","journal-title":"Pharmaceutics"},{"issue":"1","key":"4893_CR37","doi-asserted-by":"publisher","first-page":"46","DOI":"10.2119\/molmed.2013.00104","volume":"20","author":"M Sen","year":"2014","unstructured":"Sen M, Paul K, Freilino ML et al (2014) Systemic administration of a cyclic signal transducer and activator of transcription 3 (STAT3) decoy oligonucleotide inhibits tumor growth without inducing toxicological effects. Mol Med 20(1):46\u201356","journal-title":"Mol Med"},{"issue":"4","key":"4893_CR38","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1097\/CAD.0b013e32801265d7","volume":"18","author":"AN Shah","year":"2007","unstructured":"Shah AN, Gallick GE (2007) Src, chemoresistance and epithelial to mesenchymal transition: are they related? Anticancer Drugs 18(4):371\u2013375","journal-title":"Anticancer Drugs"},{"issue":"1","key":"4893_CR39","first-page":"7","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A (2022) Cancer statistics, 2022. CA Cancer J Clin 72(1):7\u201333","journal-title":"CA Cancer J Clin"},{"issue":"12","key":"4893_CR40","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1002\/mc.22438","volume":"55","author":"J Srivastava","year":"2016","unstructured":"Srivastava J, DiGiovanni J (2016) Non-canonical Stat3 signaling in cancer. Mol Carcinog 55(12):1889\u20131898","journal-title":"Mol Carcinog"},{"key":"4893_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/2044-5040-4-20","volume":"4","author":"AM Tabony","year":"2014","unstructured":"Tabony AM, Yoshida T, Sukhanov S, Delafontaine P (2014) Protein phosphatase 2C-alpha knockdown reduces angiotensin II-mediated skeletal muscle wasting via restoration of mitochondrial recycling and function. Skelet Muscle 4:20","journal-title":"Skelet Muscle"},{"issue":"1","key":"4893_CR42","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.ygyno.2010.11.017","volume":"121","author":"D Teoh","year":"2011","unstructured":"Teoh D, Ayeni TA, Rubatt JM et al (2011) Dasatinib (BMS-35482) has synergistic activity with paclitaxel and carboplatin in ovarian cancer cells. Gynecol Oncol 121(1):187\u2013192","journal-title":"Gynecol Oncol"},{"issue":"8","key":"4893_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0182282","volume":"12","author":"M Tong","year":"2017","unstructured":"Tong M, Wang J, Jiang N, Pan H, Li D (2017) Correlation between p-STAT3 overexpression and prognosis in lung cancer: a systematic review and meta-analysis. PLoS One 12(8):e0182282","journal-title":"PLoS One"},{"issue":"8","key":"4893_CR44","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1016\/j.mayocp.2019.01.034","volume":"94","author":"S Wang","year":"2019","unstructured":"Wang S, Zimmermann S, Parikh K, Mansfield AS, Adjei AA (2019) Current diagnosis and management of small-cell lung cancer. Mayo Clin Proc 94(8):1599\u20131622","journal-title":"Mayo Clin Proc"},{"key":"4893_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2020.109762","volume":"75","author":"Y Wang","year":"2020","unstructured":"Wang Y, Liu S, Jiang G et al (2020) NOK associates with c-Src and promotes c-Src-induced STAT3 activation and cell proliferation. Cell Signal 75:109762","journal-title":"Cell Signal"},{"issue":"21","key":"4893_CR46","doi-asserted-by":"publisher","first-page":"3042","DOI":"10.1111\/1759-7714.14657","volume":"13","author":"J Wang","year":"2022","unstructured":"Wang J, Li S, Zhang X et al (2022) Protein tyrosine phosphatase PTPL1 suppresses lung cancer through Src\/ERK\/YAP1 signaling. Thorac Cancer 13(21):3042\u20133051","journal-title":"Thorac Cancer"},{"key":"4893_CR47","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/1112987","volume":"2022","author":"Q Xin","year":"2022","unstructured":"Xin Q, Ji Q, Zhang Y et al (2022) Aberrant ROS served as an acquired vulnerability of cisplatin-resistant lung cancer. Oxid Med Cell Longev 2022:1112987","journal-title":"Oxid Med Cell Longev"},{"issue":"8","key":"4893_CR48","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1002\/mc.23038","volume":"58","author":"L Xu","year":"2019","unstructured":"Xu L, Qiu S, Yang L et al (2019) Aminocyanopyridines as anti-lung cancer agents by inhibiting the STAT3 pathway. Mol Carcinog 58(8):1512\u20131525","journal-title":"Mol Carcinog"},{"issue":"1","key":"4893_CR49","volume":"28","author":"L Yin","year":"2023","unstructured":"Yin L, Xu J, Wu W et al (2023) Dual inhibition of STAT3 and STAT5 may overcome imatinib resistance in chronic myeloid leukemia. Hematology (Amsterdam, Netherlands) 28(1):2224625","journal-title":"Hematology (Amsterdam, Netherlands)"},{"issue":"2","key":"4893_CR50","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nrc1275","volume":"4","author":"H Yu","year":"2004","unstructured":"Yu H, Jove R (2004) The STATs of cancer\u2013new molecular targets come of age. Nat Rev Cancer 4(2):97\u2013105","journal-title":"Nat Rev Cancer"},{"issue":"5220","key":"4893_CR51","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1126\/science.7541555","volume":"269","author":"CL Yu","year":"1995","unstructured":"Yu CL, Meyer DJ, Campbell GS et al (1995) Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein. Science 269(5220):81\u201383","journal-title":"Science"},{"issue":"1","key":"4893_CR52","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.ccr.2009.05.017","volume":"16","author":"XH Zhang","year":"2009","unstructured":"Zhang XH, Wang Q, Gerald W et al (2009) Latent bone metastasis in breast cancer tied to Src-dependent survival signals. Cancer Cell 16(1):67\u201378","journal-title":"Cancer Cell"},{"issue":"2","key":"4893_CR53","doi-asserted-by":"publisher","DOI":"10.5306\/wjco.v16.i2.97296","volume":"16","author":"XF Zhang","year":"2025","unstructured":"Zhang XF, Chen Q, Jiang Q, Hu QY (2025) Targeting STAT3 with SH-4-54 suppresses stemness and chemoresistance in cancer stem-like cells derived from colorectal cancer. World J Clin Oncol 16(2):97296","journal-title":"World J Clin Oncol"},{"issue":"2","key":"4893_CR54","doi-asserted-by":"publisher","first-page":"824","DOI":"10.7150\/thno.49600","volume":"11","author":"Q Zheng","year":"2021","unstructured":"Zheng Q, Dong H, Mo J et al (2021) A novel STAT3 inhibitor W2014-S regresses human non-small cell lung cancer xenografts and sensitizes EGFR-TKI acquired resistance. Theranostics 11(2):824\u2013840","journal-title":"Theranostics"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04893-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-025-04893-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04893-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T04:05:09Z","timestamp":1782101109000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-025-04893-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,21]]},"references-count":54,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["4893"],"URL":"https:\/\/doi.org\/10.1007\/s00210-025-04893-3","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,21]]},"assertion":[{"value":"14 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}